DWN Non-Sponsored
DWN Non-Sponsored
Advertisement
Damiana Chiavolini, PhDInfectious Disease | July 2, 2025
Piperacillin shows promise as a targeted Lyme treatment, clearing infection without harming the gut microbiome.
Damiana Chiavolini, PhDDermatology | July 2, 2025
Ucenprubart, a CD200R antibody, shows early promise for safely reducing inflammation in atopic dermatitis, per new study.
Damiana Chiavolini, PhDDermatology | July 2, 2025
JAK inhibitors show promise for vitiligo treatment, improving skin repigmentation with a favorable safety profile.
Pam BeilerGastroenterology | July 1, 2025
Wearables detect sleep changes tied to IBD inflammation—offering a new tool for real-time disease monitoring.
Rob DillardDermatology | June 30, 2025
Pollution and climate extremes may raise atopic dermatitis risk in adults.
Izzah NawazNeurodivergent | June 27, 2025
A parent-focused therapy improved asthma control and ADHD symptoms in kids—while helping caregivers cope.
Lauren Dembeck, PhDPulmonology | June 26, 2025
Digital inhaler data may predict COPD exacerbations up to 14 days early, offering a potential remote monitoring tool.
Jordana JampelGastroenterology | June 19, 2025
The low-FODMAP diet demonstrated superior reduction in IBS-SSS, but the Mediterranean diet also provided relief.
Anne Marie Morse, DOSleep Disorders | June 19, 2025
Wearable sleep tech offers insights—but are we chasing data over real rest? Dr. Anne Marie Morse weighs in.
Izzah NawazGastroenterology | June 18, 2025
SPHK2 and SPNS2 may serve as biomarkers for UC, offering new insights into diagnosis and inflammation control.
Rob Drolet, PhDNeurology | June 16, 2025
α-synuclein PET tracers may transform Parkinson’s diagnosis, tracking, and trials, says Merck’s Robert Drolet, PhD.
Leah LawrenceMental Health | June 13, 2025
Children who received a greater degree of maternal warmth at 3 years had greater perceived social safety at adolescence.
Leah LawrenceEpilepsy | June 12, 2025
Epilepsy and seizure drug use were significantly more common in patients with FTD vs those with Alzheimer’s.
Leah LawrenceGastroenterology | June 12, 2025
SLL-1-43, a selenium compound, reduced colitis symptoms in mice by targeting NOX2 and easing inflammation, oxidative stress.
Izzah NawazDermatology | June 11, 2025
Tiny particles in cow colostrum reduced eczema symptoms in mice, pointing to a potential new natural therapy.
Advertisement